Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Repare Therapeutics Inc. RPTX |
FMR CORP | 876,178 2.088% |
-2,145,135 (-71.00%) |
Filing History |
| 2023-01-06 4:19 pm Sale |
2022-12-29 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,094,451 5.000% |
-250,000 (-10.66%) |
Filing History |
| 2022-06-13 4:38 pm Sale |
2022-06-03 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,344,451 5.600% |
-250,000 (-9.64%) |
Filing History |
| 2022-06-06 5:25 pm Purchase |
2022-06-02 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.400% |
3,283,227 (+67.57%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,789,496 6.700% |
141,800 (+5.36%) |
Filing History |
| 2022-02-14 2:35 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
PRICE T ROWE ASSOCIATES INC | 2,166,822 5.100% |
2,166,822 (New Position) |
Filing History |
| 2022-02-14 09:00 am Sale |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,100,000 5.030% |
-4,600 (-0.22%) |
Filing History |
| 2022-02-11 9:11 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.600% |
1,136,363 (+30.53%) |
Filing History |
| 2022-02-11 11:36 am Sale |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
CHI Advisors LLC | 2,212,256 5.300% |
-319,894 (-12.63%) |
Filing History |
| 2022-02-09 1:48 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
ARK Investment Management LLC | 2,980,836 7.140% |
2,980,836 (New Position) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Repare Therapeutics Inc. RPTX |
FMR CORP | 3,021,313 7.239% |
263,938 (+9.57%) |
Filing History |
| 2021-11-02 5:01 pm Sale |
2021-11-01 | 13D | Repare Therapeutics Inc. RPTX |
ORBIMED ADVISORS LLC | 3,177,041 7.700% |
-99,284 (-3.03%) |
Filing History |
| 2021-10-29 4:33 pm Purchase |
2021-10-28 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,104,600 5.120% |
2,104,600 (New Position) |
Filing History |
| 2021-08-16 4:57 pm Unchanged |
2021-08-05 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,594,451 7.000% |
0 (Unchanged) |
Filing History |
| 2021-07-20 5:36 pm Sale |
2021-07-12 | 13D | Repare Therapeutics Inc. RPTX |
MPM BioVentures 2014, L.P. | 3,882,485 10.500% |
-396,746 (-9.27%) |
Filing History |
| 2021-05-25 4:06 pm Sale |
2021-05-24 | 13D | Repare Therapeutics Inc. RPTX |
MPM BioVentures 2014, L.P. | 4,279,231 11.600% |
-393,607 (-8.42%) |
Filing History |
| 2021-03-22 5:49 pm Sale |
2021-03-12 | 13D | Repare Therapeutics Inc. RPTX |
MPM BioVentures 2014, L.P. | 4,672,838 12.700% |
-719,271 (-13.34%) |
Filing History |
| 2021-03-16 5:18 pm Purchase |
2021-03-12 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.100% |
750,207 (+25.24%) |
Filing History |
| 2021-03-02 2:53 pm Purchase |
2020-12-31 | 13G | Repare Therapeutics Inc. RPTX |
CHI Advisors LLC | 2,532,150 6.900% |
2,532,150 (New Position) |
Filing History |
| 2021-02-26 4:36 pm Sale |
2021-02-16 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,594,451 7.100% |
-550,000 (-17.49%) |
Filing History |